Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5934159 | The American Journal of Pathology | 2011 | 8 Pages |
Abstract
To explore the role of antigen-specific CD4+ T cells in glomerulonephritis, we administered ovalbumin 323-339 peptide conjugated to glomerular-binding polyclonal antibody and induced disease in RAG1â/â mice with CD4+ T cells from OT2 Ã RAG1â/â mice. These OT2 Ã RAG1â/â mice have a transgenic T-cell receptor specific for this peptide. When CD4+ T cells were primed in vivo, crescentic glomerulonephritis developed after 21 days in mice given peptide-conjugated glomerular-binding antibody but not unconjugated antibody control. We then investigated the relative roles of TH1 and TH17 cells, using Fab2 fragments of glomerular-binding antibody to exclude a role for antibody in this model. T cells from OT2 Ã RAG1â/â mice were polarized in vitro, and TH1 or TH17 cell lines were injected into mice that were also given peptide-conjugated Fab2 or unconjugated Fab2 control, giving four experimental groups. After 21 days crescentic glomerulonephritis was seen in mice receiving TH17 cells and peptide-conjugated Fab2 but in none of the other three groups. These results suggest that TH17 but not TH1 cells can induce crescentic glomerulonephritis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Calogero Tulone, Angela Giorgini, Simon Freeley, Alice Coughlan, Michael Gregory Robson,